Is compounded semaglutide FDA-approved?
No. FDA approval attaches to specific products — Wegovy, Ozempic, Rybelsus, and the oral Wegovy pill — manufactured by Novo Nordisk under federal oversight. Compounded semaglutide is prepared by individual pharmacies and has never been through FDA review for safety, effectiveness, or manufacturing quality; the agency has additionally warned against unstudied salt forms (semaglutide sodium, semaglutide acetate) sometimes used in compounding. "Made in an FDA-registered facility" is not the same claim as "FDA-approved," and any marketing that blurs the two is telling you something about the marketer.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
For orientation: the verified semaglutide field spans $133 (Oak Longevity) to $348 (LifeMD↗) per month all-in as of 2026-08-09 — a $215 spread for the same molecule, made of structure rather than chemistry — while the brand lane holds $349 at maintenance via Wegovy (NovoCare↗). Coverage, where a plan grants it, outranks the whole board.
The reading rules behind every number above: figures are all-in (medication plus mandatory fees) at the maintenance dose; prepaid paths are labeled as upfront commitments; stated-not-verified flags mark claims we could not capture on a provider’s own pages; and each record carries its capture date, source link, and archive link so the answer can be checked rather than trusted. Recompute anything here from the public dataset — that reproducibility, not our word, is the warranty.
One structural fact worth carrying out of this page: the spread between the cheapest and most expensive verified way to be on the same molecule now exceeds $4,584 a year — all of it structure (memberships, tiers, wrap) rather than chemistry — while the brand lane keeps cutting underneath (Zepbound vials to $449 in December 2025, the oral pill to $149 in January 2026). In a market moving that fast, the durable skill is not knowing today’s answer but knowing how to re-derive it: all-in basis, maintenance dose, dated capture, recomputable source — the four checks the methodology formalizes.
Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.